Cullen W P, Bordner J, Huang L H, Moshier P M, Oscarson J R, Presseau L A, Ware R S, Whipple E B, Kojima Y, Maeda H
Central Research, Pfizer Inc., Groton, CT 06340.
J Ind Microbiol. 1990 Aug;5(6):365-74. doi: 10.1007/BF01578095.
CP-60,993, 19-epi-dianemycin, is a novel polycyclic ether antibiotic produced by Streptomyces hygroscopicus ATCC 39305. Fermentation recovery, purification and crystallization were achieved using standard procedures. CP-60,993 was characterized as a monocarboxylic acid. Elemental analysis suggested a molecular formula of C47H78O14 for the free acid and C47H77O14 Na for the sodium salt. Crystalline from CP-60,993 sodium salt shows the following properties: m.p. 193-205 degrees C, E1%(1 cm) = 157 at 232 nm, [alpha]25 degrees C(D) + 11.0 (c 1, methanol). The structure, determined by MS, PMR and CMR, differs from dianemycin only in the stereochemistry at position 19. This was confirmed by X-ray crystallography carried out on the rubidium salt of CP-60,993. It exhibited activity in vitro against Gram-positive and anaerobic bacteria, efficacy against Eimeria coccidia in vivo in poultry, and stimulation in vitro of rumen propionic acid production.
CP - 60,993,即19 - 表二抗菌素,是由吸水链霉菌ATCC 39305产生的一种新型多环醚抗生素。采用标准程序实现了发酵回收、纯化和结晶。CP - 60,993被鉴定为一元羧酸。元素分析表明游离酸的分子式为C47H78O14,钠盐的分子式为C47H77O14Na。CP - 60,993钠盐晶体具有以下性质:熔点193 - 205℃,在232nm处的E1%(1cm)= 157,[α]25℃(D) + 11.0(c 1,甲醇)。通过质谱、质子磁共振和碳磁共振确定的结构与二抗菌素的区别仅在于19位的立体化学。这通过对CP - 60,993铷盐进行的X射线晶体学分析得到了证实。它在体外对革兰氏阳性菌和厌氧菌具有活性,对家禽体内的艾美耳球虫有效,并且在体外能刺激瘤胃丙酸的产生。